nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP3A4—Thiotepa—urinary bladder cancer	0.0986	0.573	CbGbCtD
Dihydrocodeine—Ethylmorphine—POR—urinary bladder cancer	0.0291	0.46	CrCbGaD
Dihydrocodeine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0287	0.166	CbGbCtD
Dihydrocodeine—CYP3A4—Etoposide—urinary bladder cancer	0.0267	0.155	CbGbCtD
Dihydrocodeine—Urinary retention—Valrubicin—urinary bladder cancer	0.0232	0.0304	CcSEcCtD
Dihydrocodeine—Codeine—UGT2B7—urinary bladder cancer	0.0189	0.299	CrCbGaD
Dihydrocodeine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0182	0.106	CbGbCtD
Dihydrocodeine—Morphine—UGT2B7—urinary bladder cancer	0.0153	0.242	CrCbGaD
Dihydrocodeine—Hepatic enzyme increased—Gemcitabine—urinary bladder cancer	0.0104	0.0136	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00989	0.0129	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00982	0.0128	CcSEcCtD
Dihydrocodeine—Abdominal pain—Valrubicin—urinary bladder cancer	0.00949	0.0124	CcSEcCtD
Dihydrocodeine—Pruritus—Valrubicin—urinary bladder cancer	0.00849	0.0111	CcSEcCtD
Dihydrocodeine—Confusional state—Mitomycin—urinary bladder cancer	0.00834	0.0109	CcSEcCtD
Dihydrocodeine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00821	0.0107	CcSEcCtD
Dihydrocodeine—Urinary retention—Thiotepa—urinary bladder cancer	0.00805	0.0105	CcSEcCtD
Dihydrocodeine—Dizziness—Valrubicin—urinary bladder cancer	0.00794	0.0104	CcSEcCtD
Dihydrocodeine—Vomiting—Valrubicin—urinary bladder cancer	0.00763	0.00998	CcSEcCtD
Dihydrocodeine—Rash—Valrubicin—urinary bladder cancer	0.00757	0.0099	CcSEcCtD
Dihydrocodeine—Dermatitis—Valrubicin—urinary bladder cancer	0.00756	0.00989	CcSEcCtD
Dihydrocodeine—Headache—Valrubicin—urinary bladder cancer	0.00752	0.00984	CcSEcCtD
Dihydrocodeine—Dyspnoea—Mitomycin—urinary bladder cancer	0.00737	0.00964	CcSEcCtD
Dihydrocodeine—Somnolence—Mitomycin—urinary bladder cancer	0.00735	0.00962	CcSEcCtD
Dihydrocodeine—Nausea—Valrubicin—urinary bladder cancer	0.00713	0.00933	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00681	0.00891	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00617	0.00807	CcSEcCtD
Dihydrocodeine—Hallucination—Thiotepa—urinary bladder cancer	0.00582	0.00762	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Thiotepa—urinary bladder cancer	0.00578	0.00756	CcSEcCtD
Dihydrocodeine—Urethral disorder—Thiotepa—urinary bladder cancer	0.00574	0.00751	CcSEcCtD
Dihydrocodeine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00566	0.0074	CcSEcCtD
Dihydrocodeine—Dizziness—Mitomycin—urinary bladder cancer	0.00547	0.00715	CcSEcCtD
Dihydrocodeine—Angiopathy—Thiotepa—urinary bladder cancer	0.00531	0.00695	CcSEcCtD
Dihydrocodeine—Hepatic enzyme increased—Methotrexate—urinary bladder cancer	0.0053	0.00694	CcSEcCtD
Dihydrocodeine—Immune system disorder—Thiotepa—urinary bladder cancer	0.00529	0.00692	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00528	0.0069	CcSEcCtD
Dihydrocodeine—Vomiting—Mitomycin—urinary bladder cancer	0.00526	0.00688	CcSEcCtD
Dihydrocodeine—Rash—Mitomycin—urinary bladder cancer	0.00521	0.00682	CcSEcCtD
Dihydrocodeine—Dermatitis—Mitomycin—urinary bladder cancer	0.00521	0.00681	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00519	0.00679	CcSEcCtD
Dihydrocodeine—Headache—Mitomycin—urinary bladder cancer	0.00518	0.00678	CcSEcCtD
Dihydrocodeine—Mental disorder—Thiotepa—urinary bladder cancer	0.00513	0.00671	CcSEcCtD
Dihydrocodeine—Nausea—Mitomycin—urinary bladder cancer	0.00491	0.00643	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Gemcitabine—urinary bladder cancer	0.00486	0.00636	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00484	0.00633	CcSEcCtD
Dihydrocodeine—Urethral disorder—Gemcitabine—urinary bladder cancer	0.00483	0.00631	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Cisplatin—urinary bladder cancer	0.00453	0.00593	CcSEcCtD
Dihydrocodeine—Urethral disorder—Cisplatin—urinary bladder cancer	0.0045	0.00589	CcSEcCtD
Dihydrocodeine—Angiopathy—Gemcitabine—urinary bladder cancer	0.00447	0.00584	CcSEcCtD
Dihydrocodeine—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00445	0.00582	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00444	0.00581	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.00443	0.00579	CcSEcCtD
Dihydrocodeine—Convulsion—Thiotepa—urinary bladder cancer	0.00442	0.00578	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00431	0.00564	CcSEcCtD
Dihydrocodeine—Confusional state—Thiotepa—urinary bladder cancer	0.00419	0.00549	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Etoposide—urinary bladder cancer	0.00415	0.00543	CcSEcCtD
Dihydrocodeine—Immune system disorder—Cisplatin—urinary bladder cancer	0.00415	0.00542	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.00414	0.00541	CcSEcCtD
Dihydrocodeine—Urethral disorder—Etoposide—urinary bladder cancer	0.00412	0.00539	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00408	0.00534	CcSEcCtD
Dihydrocodeine—Skin disorder—Thiotepa—urinary bladder cancer	0.00404	0.00528	CcSEcCtD
Dihydrocodeine—Angiopathy—Etoposide—urinary bladder cancer	0.00381	0.00499	CcSEcCtD
Dihydrocodeine—Immune system disorder—Etoposide—urinary bladder cancer	0.0038	0.00497	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00379	0.00496	CcSEcCtD
Dihydrocodeine—Paraesthesia—Thiotepa—urinary bladder cancer	0.00373	0.00489	CcSEcCtD
Dihydrocodeine—Somnolence—Thiotepa—urinary bladder cancer	0.0037	0.00484	CcSEcCtD
Dihydrocodeine—Convulsion—Fluorouracil—urinary bladder cancer	0.00365	0.00478	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00362	0.00474	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00359	0.0047	CcSEcCtD
Dihydrocodeine—Constipation—Thiotepa—urinary bladder cancer	0.00356	0.00465	CcSEcCtD
Dihydrocodeine—Confusional state—Fluorouracil—urinary bladder cancer	0.00347	0.00454	CcSEcCtD
Dihydrocodeine—Convulsion—Cisplatin—urinary bladder cancer	0.00346	0.00453	CcSEcCtD
Dihydrocodeine—Mood swings—Methotrexate—urinary bladder cancer	0.00345	0.00451	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00343	0.00449	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00343	0.00448	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.0034	0.00445	CcSEcCtD
Dihydrocodeine—Skin disorder—Gemcitabine—urinary bladder cancer	0.0034	0.00445	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00338	0.00442	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00338	0.00442	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00337	0.00441	CcSEcCtD
Dihydrocodeine—Affect lability—Epirubicin—urinary bladder cancer	0.00335	0.00439	CcSEcCtD
Dihydrocodeine—Urticaria—Thiotepa—urinary bladder cancer	0.0033	0.00432	CcSEcCtD
Dihydrocodeine—Vertigo—Etoposide—urinary bladder cancer	0.00329	0.0043	CcSEcCtD
Dihydrocodeine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00329	0.0043	CcSEcCtD
Dihydrocodeine—Hypotension—Gemcitabine—urinary bladder cancer	0.00327	0.00428	CcSEcCtD
Dihydrocodeine—Mood swings—Epirubicin—urinary bladder cancer	0.00323	0.00422	CcSEcCtD
Dihydrocodeine—Hypotension—Fluorouracil—urinary bladder cancer	0.00321	0.0042	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.0032	0.00418	CcSEcCtD
Dihydrocodeine—Convulsion—Etoposide—urinary bladder cancer	0.00317	0.00415	CcSEcCtD
Dihydrocodeine—Skin disorder—Cisplatin—urinary bladder cancer	0.00317	0.00414	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00315	0.00412	CcSEcCtD
Dihydrocodeine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00314	0.00411	CcSEcCtD
Dihydrocodeine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00312	0.00408	CcSEcCtD
Dihydrocodeine—Somnolence—Gemcitabine—urinary bladder cancer	0.00311	0.00407	CcSEcCtD
Dihydrocodeine—Affect lability—Doxorubicin—urinary bladder cancer	0.0031	0.00406	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00309	0.00405	CcSEcCtD
Dihydrocodeine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00309	0.00404	CcSEcCtD
Dihydrocodeine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00307	0.00401	CcSEcCtD
Dihydrocodeine—Somnolence—Fluorouracil—urinary bladder cancer	0.00306	0.004	CcSEcCtD
Dihydrocodeine—Hypotension—Cisplatin—urinary bladder cancer	0.00305	0.00399	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00302	0.00395	CcSEcCtD
Dihydrocodeine—Confusional state—Etoposide—urinary bladder cancer	0.00301	0.00394	CcSEcCtD
Dihydrocodeine—Constipation—Gemcitabine—urinary bladder cancer	0.00299	0.00391	CcSEcCtD
Dihydrocodeine—Mood swings—Doxorubicin—urinary bladder cancer	0.00299	0.00391	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00297	0.00388	CcSEcCtD
Dihydrocodeine—Pruritus—Thiotepa—urinary bladder cancer	0.00294	0.00385	CcSEcCtD
Dihydrocodeine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00293	0.00383	CcSEcCtD
Dihydrocodeine—Dyspnoea—Cisplatin—urinary bladder cancer	0.00291	0.0038	CcSEcCtD
Dihydrocodeine—Skin disorder—Etoposide—urinary bladder cancer	0.0029	0.0038	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00289	0.00378	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00288	0.00377	CcSEcCtD
Dihydrocodeine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00285	0.00372	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00283	0.00371	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00282	0.00368	CcSEcCtD
Dihydrocodeine—Hypotension—Etoposide—urinary bladder cancer	0.00279	0.00365	CcSEcCtD
Dihydrocodeine—Dizziness—Thiotepa—urinary bladder cancer	0.00275	0.0036	CcSEcCtD
Dihydrocodeine—Urticaria—Fluorouracil—urinary bladder cancer	0.00273	0.00357	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00269	0.00352	CcSEcCtD
Dihydrocodeine—Paraesthesia—Etoposide—urinary bladder cancer	0.00268	0.00351	CcSEcCtD
Dihydrocodeine—Dyspnoea—Etoposide—urinary bladder cancer	0.00266	0.00348	CcSEcCtD
Dihydrocodeine—Somnolence—Etoposide—urinary bladder cancer	0.00266	0.00347	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00265	0.00347	CcSEcCtD
Dihydrocodeine—Vomiting—Thiotepa—urinary bladder cancer	0.00264	0.00346	CcSEcCtD
Dihydrocodeine—Rash—Thiotepa—urinary bladder cancer	0.00262	0.00343	CcSEcCtD
Dihydrocodeine—Dermatitis—Thiotepa—urinary bladder cancer	0.00262	0.00343	CcSEcCtD
Dihydrocodeine—Headache—Thiotepa—urinary bladder cancer	0.00261	0.00341	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00258	0.00337	CcSEcCtD
Dihydrocodeine—Constipation—Etoposide—urinary bladder cancer	0.00255	0.00334	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00249	0.00325	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.00248	0.00325	CcSEcCtD
Dihydrocodeine—Pruritus—Gemcitabine—urinary bladder cancer	0.00248	0.00324	CcSEcCtD
Dihydrocodeine—Nausea—Thiotepa—urinary bladder cancer	0.00247	0.00323	CcSEcCtD
Dihydrocodeine—Urethral disorder—Methotrexate—urinary bladder cancer	0.00247	0.00323	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00246	0.00322	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00244	0.0032	CcSEcCtD
Dihydrocodeine—Pruritus—Fluorouracil—urinary bladder cancer	0.00243	0.00318	CcSEcCtD
Dihydrocodeine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00239	0.00313	CcSEcCtD
Dihydrocodeine—Urticaria—Etoposide—urinary bladder cancer	0.00237	0.0031	CcSEcCtD
Dihydrocodeine—Abdominal pain—Etoposide—urinary bladder cancer	0.00236	0.00309	CcSEcCtD
Dihydrocodeine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00235	0.00308	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00233	0.00304	CcSEcCtD
Dihydrocodeine—Urethral disorder—Epirubicin—urinary bladder cancer	0.00231	0.00302	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.0023	0.00301	CcSEcCtD
Dihydrocodeine—Angiopathy—Methotrexate—urinary bladder cancer	0.00229	0.00299	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methotrexate—urinary bladder cancer	0.00227	0.00298	CcSEcCtD
Dihydrocodeine—Dizziness—Fluorouracil—urinary bladder cancer	0.00227	0.00298	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00227	0.00297	CcSEcCtD
Dihydrocodeine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00223	0.00292	CcSEcCtD
Dihydrocodeine—Vomiting—Gemcitabine—urinary bladder cancer	0.00222	0.00291	CcSEcCtD
Dihydrocodeine—Mental disorder—Methotrexate—urinary bladder cancer	0.00221	0.00289	CcSEcCtD
Dihydrocodeine—Rash—Gemcitabine—urinary bladder cancer	0.00221	0.00289	CcSEcCtD
Dihydrocodeine—Dermatitis—Gemcitabine—urinary bladder cancer	0.0022	0.00288	CcSEcCtD
Dihydrocodeine—Headache—Gemcitabine—urinary bladder cancer	0.00219	0.00287	CcSEcCtD
Dihydrocodeine—Vomiting—Fluorouracil—urinary bladder cancer	0.00219	0.00286	CcSEcCtD
Dihydrocodeine—Rash—Fluorouracil—urinary bladder cancer	0.00217	0.00284	CcSEcCtD
Dihydrocodeine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00217	0.00283	CcSEcCtD
Dihydrocodeine—Headache—Fluorouracil—urinary bladder cancer	0.00215	0.00282	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00215	0.00282	CcSEcCtD
Dihydrocodeine—Angiopathy—Epirubicin—urinary bladder cancer	0.00214	0.0028	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00214	0.0028	CcSEcCtD
Dihydrocodeine—Immune system disorder—Epirubicin—urinary bladder cancer	0.00213	0.00278	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00212	0.00278	CcSEcCtD
Dihydrocodeine—Pruritus—Etoposide—urinary bladder cancer	0.00211	0.00276	CcSEcCtD
Dihydrocodeine—Nausea—Gemcitabine—urinary bladder cancer	0.00208	0.00272	CcSEcCtD
Dihydrocodeine—Vomiting—Cisplatin—urinary bladder cancer	0.00207	0.00271	CcSEcCtD
Dihydrocodeine—Mental disorder—Epirubicin—urinary bladder cancer	0.00206	0.0027	CcSEcCtD
Dihydrocodeine—Rash—Cisplatin—urinary bladder cancer	0.00206	0.00269	CcSEcCtD
Dihydrocodeine—Dermatitis—Cisplatin—urinary bladder cancer	0.00205	0.00269	CcSEcCtD
Dihydrocodeine—Diarrhoea—Etoposide—urinary bladder cancer	0.00204	0.00267	CcSEcCtD
Dihydrocodeine—Nausea—Fluorouracil—urinary bladder cancer	0.00204	0.00267	CcSEcCtD
Dihydrocodeine—Angiopathy—Doxorubicin—urinary bladder cancer	0.00198	0.00259	CcSEcCtD
Dihydrocodeine—Dizziness—Etoposide—urinary bladder cancer	0.00198	0.00258	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00197	0.00258	CcSEcCtD
Dihydrocodeine—Vertigo—Methotrexate—urinary bladder cancer	0.00197	0.00258	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00197	0.00257	CcSEcCtD
Dihydrocodeine—Nausea—Cisplatin—urinary bladder cancer	0.00194	0.00253	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—urinary bladder cancer	0.00191	0.0025	CcSEcCtD
Dihydrocodeine—Convulsion—Methotrexate—urinary bladder cancer	0.0019	0.00248	CcSEcCtD
Dihydrocodeine—Vomiting—Etoposide—urinary bladder cancer	0.0019	0.00248	CcSEcCtD
Dihydrocodeine—Rash—Etoposide—urinary bladder cancer	0.00188	0.00246	CcSEcCtD
Dihydrocodeine—Dermatitis—Etoposide—urinary bladder cancer	0.00188	0.00246	CcSEcCtD
Dihydrocodeine—Headache—Etoposide—urinary bladder cancer	0.00187	0.00245	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00185	0.00242	CcSEcCtD
Dihydrocodeine—Vertigo—Epirubicin—urinary bladder cancer	0.00184	0.00241	CcSEcCtD
Dihydrocodeine—Confusional state—Methotrexate—urinary bladder cancer	0.0018	0.00236	CcSEcCtD
Dihydrocodeine—Convulsion—Epirubicin—urinary bladder cancer	0.00178	0.00233	CcSEcCtD
Dihydrocodeine—Nausea—Etoposide—urinary bladder cancer	0.00177	0.00232	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00175	0.0023	CcSEcCtD
Dihydrocodeine—Skin disorder—Methotrexate—urinary bladder cancer	0.00174	0.00227	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00173	0.00227	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00173	0.00226	CcSEcCtD
Dihydrocodeine—Dry mouth—Epirubicin—urinary bladder cancer	0.00171	0.00223	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—urinary bladder cancer	0.00171	0.00223	CcSEcCtD
Dihydrocodeine—Confusional state—Epirubicin—urinary bladder cancer	0.00169	0.00221	CcSEcCtD
Dihydrocodeine—Hypotension—Methotrexate—urinary bladder cancer	0.00167	0.00219	CcSEcCtD
Dihydrocodeine—Convulsion—Doxorubicin—urinary bladder cancer	0.00164	0.00215	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00164	0.00215	CcSEcCtD
Dihydrocodeine—Skin disorder—Epirubicin—urinary bladder cancer	0.00163	0.00213	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00162	0.00212	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methotrexate—urinary bladder cancer	0.00161	0.0021	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00161	0.0021	CcSEcCtD
Dihydrocodeine—Dyspnoea—Methotrexate—urinary bladder cancer	0.0016	0.00209	CcSEcCtD
Dihydrocodeine—Somnolence—Methotrexate—urinary bladder cancer	0.00159	0.00208	CcSEcCtD
Dihydrocodeine—Dry mouth—Doxorubicin—urinary bladder cancer	0.00158	0.00207	CcSEcCtD
Dihydrocodeine—Hypotension—Epirubicin—urinary bladder cancer	0.00156	0.00205	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—urinary bladder cancer	0.00156	0.00204	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00154	0.00202	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00152	0.00199	CcSEcCtD
Dihydrocodeine—Skin disorder—Doxorubicin—urinary bladder cancer	0.00151	0.00197	CcSEcCtD
Dihydrocodeine—Paraesthesia—Epirubicin—urinary bladder cancer	0.0015	0.00197	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.0015	0.00196	CcSEcCtD
Dihydrocodeine—Dyspnoea—Epirubicin—urinary bladder cancer	0.00149	0.00195	CcSEcCtD
Dihydrocodeine—Somnolence—Epirubicin—urinary bladder cancer	0.00149	0.00195	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00147	0.00193	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00146	0.00191	CcSEcCtD
Dihydrocodeine—Hypotension—Doxorubicin—urinary bladder cancer	0.00145	0.00189	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00145	0.00189	CcSEcCtD
Dihydrocodeine—Constipation—Epirubicin—urinary bladder cancer	0.00143	0.00187	CcSEcCtD
Dihydrocodeine—Urticaria—Methotrexate—urinary bladder cancer	0.00142	0.00186	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methotrexate—urinary bladder cancer	0.00141	0.00185	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00139	0.00182	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00138	0.00181	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00138	0.00181	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—urinary bladder cancer	0.00138	0.0018	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00137	0.00179	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00134	0.00175	CcSEcCtD
Dihydrocodeine—Urticaria—Epirubicin—urinary bladder cancer	0.00133	0.00174	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—urinary bladder cancer	0.00132	0.00173	CcSEcCtD
Dihydrocodeine—Abdominal pain—Epirubicin—urinary bladder cancer	0.00132	0.00173	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00128	0.00167	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00127	0.00166	CcSEcCtD
Dihydrocodeine—Pruritus—Methotrexate—urinary bladder cancer	0.00127	0.00166	CcSEcCtD
Dihydrocodeine—Urticaria—Doxorubicin—urinary bladder cancer	0.00123	0.00161	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00122	0.0016	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methotrexate—urinary bladder cancer	0.00122	0.0016	CcSEcCtD
Dihydrocodeine—Pruritus—Epirubicin—urinary bladder cancer	0.00118	0.00155	CcSEcCtD
Dihydrocodeine—Dizziness—Methotrexate—urinary bladder cancer	0.00118	0.00155	CcSEcCtD
Dihydrocodeine—Diarrhoea—Epirubicin—urinary bladder cancer	0.00115	0.0015	CcSEcCtD
Dihydrocodeine—Vomiting—Methotrexate—urinary bladder cancer	0.00114	0.00149	CcSEcCtD
Dihydrocodeine—Rash—Methotrexate—urinary bladder cancer	0.00113	0.00148	CcSEcCtD
Dihydrocodeine—Dermatitis—Methotrexate—urinary bladder cancer	0.00113	0.00147	CcSEcCtD
Dihydrocodeine—Headache—Methotrexate—urinary bladder cancer	0.00112	0.00147	CcSEcCtD
Dihydrocodeine—Dizziness—Epirubicin—urinary bladder cancer	0.00111	0.00145	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—urinary bladder cancer	0.0011	0.00143	CcSEcCtD
Dihydrocodeine—Vomiting—Epirubicin—urinary bladder cancer	0.00106	0.00139	CcSEcCtD
Dihydrocodeine—Nausea—Methotrexate—urinary bladder cancer	0.00106	0.00139	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00106	0.00139	CcSEcCtD
Dihydrocodeine—Rash—Epirubicin—urinary bladder cancer	0.00106	0.00138	CcSEcCtD
Dihydrocodeine—Dermatitis—Epirubicin—urinary bladder cancer	0.00105	0.00138	CcSEcCtD
Dihydrocodeine—Headache—Epirubicin—urinary bladder cancer	0.00105	0.00137	CcSEcCtD
Dihydrocodeine—Dizziness—Doxorubicin—urinary bladder cancer	0.00102	0.00134	CcSEcCtD
Dihydrocodeine—Nausea—Epirubicin—urinary bladder cancer	0.000995	0.0013	CcSEcCtD
Dihydrocodeine—Vomiting—Doxorubicin—urinary bladder cancer	0.000985	0.00129	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—urinary bladder cancer	0.000977	0.00128	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000976	0.00128	CcSEcCtD
Dihydrocodeine—Headache—Doxorubicin—urinary bladder cancer	0.000971	0.00127	CcSEcCtD
Dihydrocodeine—Nausea—Doxorubicin—urinary bladder cancer	0.00092	0.0012	CcSEcCtD
